Trial Profile
Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Mar 2010
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Cardiovascular disorders; Type 2 diabetes mellitus; Vascular disorders
- Focus Therapeutic Use
- Sponsors Takeda
- 10 Sep 2008 New trial record.